1. Aspden P, Institute of Medicine (USA), Committee on Identifying and Preventing Medication Errors Preventing medication errors. Washington, DC: National Academies Press, 2007 [Google Scholar] 2. Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS data brief, no 42. Hyattsville, MD: National Center for Health Statistics. 2010. In: Statistics NCfH, ed. Vol 42. Hyattsville, MD: NCHS Data Brief 2010 [PubMed] 3. Gardella JE, Cardwell TB, Nnadi M. Improving medication safety with accurate preadmission medication lists and postdischarge education. Jt Comm J Qual Patient Saf 2012;38:452–8 [PubMed] [Google Scholar] 4. Polischuk E, Vetterly CG, Crowley KL, et al. Implementation of a standardized process for ordering and dispensing of high-alert emergency medication infusions. J Pediatr Pharmacol Ther 2012;17:166–72 [PMC free article] [PubMed] [Google Scholar] 5. Velez-Diaz-Pallares M, Delgado-Silveira E, Carretero-Accame ME, et al. Using healthcare failure mode and effect analysis to reduce medication errors in the process of drug prescription, validation and dispensing in hospitalised patients. BMJ Qual Saf 2013;22:42–52 [PubMed] [Google Scholar] 6. Abrashkin KA, Cho HJ, Torgalkar S, et al. Improving transitions of care from hospital to home: what works? Mt Sinai J Med 2012;79:535–44 [PubMed] [Google Scholar] 7. Moore SR, Morris LA, Groft SC. The history of patient package inserts in the United States. Can Pharm J 1981;114:173–5 [PubMed] [Google Scholar] 8. US Food and Drug Administration Strategies to reduce medication errors: working to improve medication safet. Silver Spring, MD: US FDA, 2011 [Google Scholar] 9. Stavroudis TA, Miller MR, Lehmann CU. Medication errors in neonates. Clin Perinatol 2008;35:141–61; ix [PubMed] [Google Scholar] 10. Office of the Commisioner, FDA Guidance for industry: providing regulatory submissions in electronic format—drug establishment registration and drug listing. In: US Department of Health and Human Services, Rockville, MD: Center for Biologics Evaluation and Research, FDA, 2009 [Google Scholar] 11. Food and Drug Administration HHS. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule. Fed Regist 2003;68:69009–20 [PubMed] [Google Scholar] 12. Ruchalski C. The paperless labeling initiative: a proof-of-concept study. Ann Pharmacother 2004;38:1178–82 [PubMed] [Google Scholar] 13. Kotter JP. Leading change: why transformation efforts fail. Harv Bus Rev 1995;73:59–67 [Google Scholar] 14. de Leon J. Highlights of drug package inserts and the website DailyMed: the need for further improvement in package inserts to help busy prescribers. J Clin Psychopharmacol 2011;31:263–5 [PubMed] [Google Scholar] 15. Davis TC, Wolf MS, Bass PF, III, et al. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med 2006;21:847–51 [PMC free article] [PubMed] [Google Scholar] 16. Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 2011;155:97–107 [PubMed] [Google Scholar] 17. Kripalani S, Henderson LE, Chiu EY, et al. Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med 2006;21:852–6 [PMC free article] [PubMed] [Google Scholar] 18. Pignone M, DeWalt DA, Sheridan S, et al. Interventions to improve health outcomes for patients with low literacy. A systematic review. J Gen Intern Med 2005;20:185–92 [PMC free article] [PubMed] [Google Scholar]
Our Marking and Labeling Systems Program covers labels, nameplates or markers, label materials, and related products that have been submitted for evaluation in accordance with prescribed permanence of marking performance requirements so that they can be used to display safety-related information on products. Many electrical, electronic and related technology products are required to be permanently marked with specific safety-related information including hazards, warnings, cautionary markings, installation instructions and electrical ratings. Labels and related products that comply with the Marking and Labeling Systems requirements fall under UL Solutions’ Component Certification Program. This program provides a convenient way for product manufacturers to acquire labels that meet marking performance requirements applicable to their UL Certified products. Marking and Labeling Systems are covered under the following six categories based on the type of product and end-use application:
In addition, UL Solutions evaluates to Canadian requirements under CCN PGDQ8, PGJI8, PGIM8 and PGGU8 — that are tested in accordance with the test methods in the Canadian standard, Canadian Standards Association (CSA) C22.2 No. 0.15, Adhesive Labels and under CCN PGCT8 that are tested accordance with the test methods in ANSI/CAN/UL 969A. All recognized component marking and labeling systems are intended for application at an end-use product factory and fall under UL Solutions’ Follow-Up Services program. This program states that UL Certified products must continue to be manufactured in compliance with UL Solutions’ requirements. A brief description of each category and corresponding with CCN can be found further down this webpage. Testing/Evaluation Evaluation for Marking and Labeling Systems recognition includes a construction examination and testing for permanency. Environmental conditioning of labels typically includes testing for exposure to high humidity or occasional exposure to water, elevated temperatures, sunlight or chemical agents. After environmental conditioning, labels are visually examined for curling, wrinkling, shrinkage or loss of adhesion around the perimeter. Testing also typically includes evaluation of legibility, resistance to defacement and adhesion. Conditions of acceptability Guidelines addressing the suitability of marking and labeling systems when used with an end product are included in the UL Solutions report under Conditions of Acceptability. The Conditions of Acceptability generally cover application surfaces, temperature ratings and additional exposure conditions for which the product was found acceptable. The Conditions of Acceptability may also include print color limitations, label size limitations and special-use applications. The Conditions of Acceptability are also published in the UL Product iQ™ database. Label adoption Label converters and printers that use recognized label materials, such as label stocks, laminating adhesives and overlaminations, can benefit from the recognition established for the label material when establishing recognition for their printed labels. This process is known as label adoption. Marking and labeling systems categories A brief description of each certification category and corresponding CCN covered under Marking and Labeling Systems at UL Solutions can be found below.
Recognition for Canada Under the Canadian Certification Program, UL Solutions tests products to CSA C22.2 No. 0.15 and ANSI/CAN/UL 969A. As the CSA C22.2 No. 0.15 standard includes test methods that differ from UL 969, additional testing is necessary to grant Canadian Recognition. Products found to comply with the Canadian requirements are marked with the Canadian UL Recognition Mark. Products certified for Canada are published under category code numbers PGDQ8, PGJI8, PGIM8, PGGU8 and PGCT8. Labels evaluated to the requirements of other standards While all products recognized in PGDQ2, PGJI2, PGIM2 and PGGU2 have been evaluated in accordance with ANSI/UL 969, some products may also be evaluated for specific end-use applications — including portable ladders and fire extinguishers — where the governing standard has requirements that go beyond those in ANSI/UL 969. In addition, UL Solutions evaluates labels to the British Standard (BS) 5609:1986, Specification for printed pressure-sensitive, adhesive-coated labels for marine use, under CCN PGDT2. BenefitsWe are uniquely positioned to provide a complete view of how products function within a given system. This is particularly critical in the plastics and components industry, as interactions between substances, parts, systems and the environment can cause a significant number of hazards. These failures are rarely apparent when components are tested individually. Our technical experts can also help align your products to the appropriate UL Certification category and the applicable Standards. This enables manufacturers of UL Certified products to easily source components that demonstrably meet their compliance needs and project specifications. Our trustworthy reputation provides an important product differentiator in a crowded marketplace. Working with us is just one more way that you can communicate your product’s safety and quality to original equipment manufacturers (OEMs), purchasers and regulatory authorities. Why UL SolutionsUL Solutions’ comprehensive testing, certification, assessment and regulatory compliance services are designed to foster innovation, enhance product and process quality, enable safety, and, most importantly, help you meet your business goals. Our broad capabilities enable us to help you address a wide variety of key business needs that may arise throughout your product development life cycle and deployment phase. Working with one provider allows you to take advantage of our cost- and time-saving service bundles. Our integrated testing and certification plans allow you to achieve your go-to-market plans in a timely manner. |